Scribd Logo
Upload

Welcome to Scribd!

  • 104 views

    Hepatitis D: Pathophysiology

    Uploaded by

    Yanna Habib-Mangotara
    Hepatitis D is caused by the hepatitis D virus, which is a small circular RNA virus. It can only propagate in individuals infected with hepatitis B. Coinfection or superinfection with hepatitis D results in more severe liver disease compared to hepatitis B alone, including a higher risk of liver failure, cirrhosis, and liver cancer. Hepatitis D has the highest mortality rate of all hepatitis viruses at around 20%. The virus infects liver cells, causing inflammation and cell death in the liver. While there is no vaccine for hepatitis D, treatment may involve targeting the hepatitis B virus since hepatitis D requires hepatitis B to replicate.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd

    Hepatitis D: Pathophysiology

    Uploaded by

    Yanna Habib-Mangotara
    104 views2 pages
    Hepatitis D is caused by the hepatitis D virus, which is a small circular RNA virus. It can only propagate in individuals infected with hepatitis B. Coinfection or superinfection with hepatitis D results in more severe liver disease compared to hepatitis B alone, including a higher risk of liver failure, cirrhosis, and liver cancer. Hepatitis D has the highest mortality rate of all hepatitis viruses at around 20%. The virus infects liver cells, causing inflammation and cell death in the liver. While there is no vaccine for hepatitis D, treatment may involve targeting the hepatitis B virus since hepatitis D requires hepatitis B to replicate.

    Original Description:

    STDs

    Original Title

    Hepatitis D

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Hepatitis D is caused by the hepatitis D virus, which is a small circular RNA virus. It can only propagate in individuals infected with hepatitis B. Coinfection or superinfection with hepatitis D results in more severe liver disease compared to hepatitis B alone, including a higher risk of liver failure, cirrhosis, and liver cancer. Hepatitis D has the highest mortality rate of all hepatitis viruses at around 20%. The virus infects liver cells, causing inflammation and cell death in the liver. While there is no vaccine for hepatitis D, treatment may involve targeting the hepatitis B virus since hepatitis D requires hepatitis B to replicate.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    104 views2 pages

    Hepatitis D: Pathophysiology

    Uploaded by

    Yanna Habib-Mangotara
    Hepatitis D is caused by the hepatitis D virus, which is a small circular RNA virus. It can only propagate in individuals infected with hepatitis B. Coinfection or superinfection with hepatitis D results in more severe liver disease compared to hepatitis B alone, including a higher risk of liver failure, cirrhosis, and liver cancer. Hepatitis D has the highest mortality rate of all hepatitis viruses at around 20%. The virus infects liver cells, causing inflammation and cell death in the liver. While there is no vaccine for hepatitis D, treatment may involve targeting the hepatitis B virus since hepatitis D requires hepatitis B to replicate.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 2

    HEPATITIS D

    Hepatitis D, also referred to as hepatitis D virus (HDV) and classified as Hepatitis delta virus, is a disease caused by a small circular enveloped RNA virus. It is one of five known hepatitis viruses: A, B, C, D, and E. HDV is considered to be a subviral satellite because it can propagate only in the presence of the hepatitis B virus (HBV). Transmission of HDV can occur either via simultaneous infection with HBV (coinfection) or via infection of an individual previously infected with HBV (superinfection). Both superinfection and coinfection with HDV results in more severe complications compared to infection with HBV alone. These complications include a greater likelihood of experiencing liver failure in acute infections and a rapid progression to liver cirrhosis, with an increased chance of developing liver cancer in chronic infections.[2] In combination with hepatitis B virus, hepatitis D has the highest mortality rate of all the hepatitis infections of 20%. Pathophysiology The etiologic agent, mode of transmission, and clinical course vary according to the hepatitis type. However, the pathophysiology is the same. The causative agent invades the mononuclear cells in the liver, replicates, and sets up an inflammatory process in the parenchyma and portal ducts, causing hepatic cell necrosis, cellular collapse, and accumulation of necrotic tissue in the lobules and portal ducts. This results in interference with bilirubin excretion. Cellular regeneration and mitosis occur simultaneously with cellular necrosis, and the liver regenerates within 2 to 3 months. Continuation of the inflammatory response sets up a chronic disease process. Causative Agent Targeting the causative agent of Hepatitis B may also kill the causative agent of Hepatitis D.

    Incubation Period HAV: 15 to 50 days; HBV: 45 to 180 days; HCV: 14 to 182 days; HDV: 14 to 70 days; HEV: 15 to 64 days Communicability HAV: last half of incubation until 1 week after onset of jaundice; HBV: during incubation and entire clinical course (carrier state may persist for years); HCV: 1 week before clinical onset to indefinite period of time as carrier; HDV: throughout clinical disease; HEV: unknown Medical Management 1. Targeting the causative agent of Hepatitis B may also kill the causative agent of Hepatitis D. 2. Interferon is under investigation as a specific treatment for Hepatitis D. 3. Acyclovir, ribavirin, lamivudine and synthetic analogues of thymosin have proved ineffective. Nursing Management 1. Inform the patient and family members about the nature of the disease if the patient is taken care at home. 2. Assist is paracentesis if indicated. 3. Patients with cirrhosis could be in deep pain and discomfort, use of analgesics should be administered with great caution since it can worsen the liver damage. 4. Diversionary therapy and non-pharmacological approach should be applied in managing pain. 5. Ongoing monitoring of vital signs, abdominal girth and reminding for the routine check-up must be emphasized for effective management.Photo credits: www.google.com.ph

    You might also like